Compounds modulating function of telomeric proteins TRF1 and TRF2

2023/49/B/NZ7/03456

Keywords

Descriptors

  • NZ7_14: Farmacja, farmakoterapia, farmakologia
  • NZ5_07: Leczenie chorób człowieka
  • ST5_15: Chemia medyczna

Panel

NZ7 – Diagnostic tools, therapies and public health: public health, epidemiology, environmental health risks and occupational medicine, medical ethics, drug discovery and therapies, pharmacology

Host institution

Politechnika Gdańska, Wydział Chemiczny

Voivodeship: pomorskie

Other projects carried out by the institution »

Principal investigator (from the host institution)

prof. Maciej Wojciech Bagiński

Number of co-investigators in the project: 13

Call

OPUS 25 – announced on 2023-03-16

Amount awarded
2 813 440 PLN
Project start date
2024-01-29
Project end date
2028-01-28
Project duration
48 months (the same as in the proposal)
Project status
Pending project

Project description

Download the project description in a pdf file

Note — project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.

Information in the final report

Publication in academic press/journals (1)

  1. Targeting shelterin proteins for cancer therapy

    Authors:
    Wioletta Brankiewicz-Kopcinska, Anoop Kallingal, Radoslaw Krzemieniecki, Maciej Baginski
    Academic press:
    Drug Discovery Today (year: 2024, volume: 29, pages: 104056), Publisher: Elsevier
    Status:
    Published
    DOI:
    10.1016/j.drudis.2024.104056 – link to the publication

« New search

Graphic design and implementation: Jakub Piotrowski